Advances in biomarker development are revolutionizing the way we study, diagnose and treat disease. However, progress in the development and use of biomarkers for diseases of the central nervous system has been limited by a number of difficulties -- including the inherent barriers associated with studying the brain. Development of reliable biomarkers for brain disorders would dramatically accelerate research on the etiology, pathophysiology, disease progression, and therapeutic development of many very prevalent and ...
Read More
Advances in biomarker development are revolutionizing the way we study, diagnose and treat disease. However, progress in the development and use of biomarkers for diseases of the central nervous system has been limited by a number of difficulties -- including the inherent barriers associated with studying the brain. Development of reliable biomarkers for brain disorders would dramatically accelerate research on the etiology, pathophysiology, disease progression, and therapeutic development of many very prevalent and devastating diseases including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. International experts in the field have contributed chapters to this volume that discuss the latest advances in biomarker technologies and biomarker development for brain disorders, as well as the logistical, regulatory and funding challenges experienced by scientists working on clinical trials for biomarkers NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit ... ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order ( ... Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http: //... for more information about becoming a member.
Read Less
Add this copy of Biomarkers in Brain Disease (Annals of the New York to cart. $14.88, like new condition, Sold by Zubal Books rated 4.0 out of 5 stars, ships from Cleveland, OH, UNITED STATES, published 2009 by Wiley-Blackwell.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
*Price HAS BEEN REDUCED by 10% until Monday, Jan. 6 (SALE ITEM)* 124 pp., Paperback, hand stamp to title page else fine. -If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Add this copy of Biomarkers in Brain Disease, Volume 1180 to cart. $112.56, good condition, Sold by ThriftBooks-Reno rated 5.0 out of 5 stars, ships from Reno, NV, UNITED STATES, published 2009 by Wiley-Blackwell.
Add this copy of Biomarkers in Brain Disease Vol 1180 (Pb 2009) to cart. $113.14, Sold by Books International rated 4.0 out of 5 stars, ships from Toronto, ON, CANADA, published 2009 by Wiley-Blackwell.
Add this copy of Biomarkers in Brain Disease to cart. $133.20, new condition, Sold by Media Smart rated 4.0 out of 5 stars, ships from Hawthorne, CA, UNITED STATES, published 2009 by New York Academy of Sciences.
Add this copy of Biomarkers in Brain Disease Vol 1180 (Pb 2009) to cart. $149.06, new condition, Sold by discount_scientific_books rated 5.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2009 by Wiley-Blackwell.
